Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the operating margin high or low?
The operating margin of -466.16% is 15% above its 5-year average of -549.41%, around the middle of its 5-year range (-1680.60%–430.39%).
23.54% above its 12-month average of -609.69%.
Reported quarterly operating margin; no daily interpolation. Q2 FY2026 (2026-06-30): -1334.89%.
OPERATING MARGIN
-466.16%
OPERATING MARGIN AVG TTM
-609.69%
OPERATING MARGIN AVG 3Y
-493.30%
OPERATING MARGIN AVG 5Y
-549.41%
OPERATING MARGIN AVG 10Y
N/A
OPERATING MARGIN AVG 15Y
N/A
OPERATING MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+23.54%
CURRENT VS 3Y AVG
+5.50%
CURRENT VS 5Y AVG
+15.15%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.00%
median of 678 covered companies
CURRENT VS SECTOR MEDIAN
N/A
vs the sector median at left
Nano-X Imaging Ltd.
Market Cap
$44.18M
Operating Margin
-466.16%
TTM Avg
-609.69%
3Y Avg
-493.30%
5Y Avg
-549.41%
Market Cap
$44.31M
Operating Margin
-163.94%
TTM Avg
-188.75%
3Y Avg
-214.75%
5Y Avg
-271.10%
Market Cap
$44.50M
Operating Margin
-1.45%
TTM Avg
4.45%
3Y Avg
-26.46%
5Y Avg
-35.98%
Market Cap
$43.25M
Operating Margin
-90.49%
TTM Avg
-103.23%
3Y Avg
-126.36%
5Y Avg
-149.14%
Market Cap
$45.20M
Operating Margin
0.00%
TTM Avg
-1952.10%
3Y Avg
-1112.27%
5Y Avg
-741.51%
Market Cap
$41.92M
Operating Margin
-5.63%
TTM Avg
-15.71%
3Y Avg
-54.38%
5Y Avg
-79.38%
Market Cap
$41.77M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$40.28M
Operating Margin
-380.85%
TTM Avg
-275.43%
3Y Avg
-246.44%
5Y Avg
-2168.10%
Market Cap
$48.15M
Operating Margin
0.00%
TTM Avg
0.00%
3Y Avg
-13.26%
5Y Avg
-68.70%
| NAME | MARKET CAP | OPERATING MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Nano-X Imaging Ltd. (NNOX) | $44.18M | -466.16% | -609.69% | -493.30% | -549.41% |
| DarioHealth Corp. (DRIO)vs › | $44.31M | -163.94% | -188.75% | -214.75% | -271.10% |
| BioStem Technologies, Inc. (BSEM)vs › | $44.50M | -1.45% | 4.45% | -26.46% | -35.98% |
| CVRx, Inc. (CVRX)vs › | $43.25M | -90.49% | -103.23% | -126.36% | -149.14% |
| Werewolf Therapeutics, Inc. (HOWL)vs › | $45.20M | 0.00% | -1952.10% | -1112.27% | -741.51% |
| Precipio, Inc. (PRPO)vs › | $41.92M | -5.63% | -15.71% | -54.38% | -79.38% |
| Filana Therapeutics, Inc. (FLNA)vs › | $41.77M | 0.00% | 0.00% | 0.00% | 0.00% |
| Metagenomi, Inc. Common Stock (MGX)vs › | $40.28M | -380.85% | -275.43% | -246.44% | -2168.10% |
| Lite Strategy, Inc. (LITS)vs › | $48.15M | 0.00% | 0.00% | -13.26% | -68.70% |
| Precision Optics Corporation, Inc. (POCI)vs › | $48.32M | -11.13% | -20.11% | -14.38% | -12.43% |
Gross Margin
-98.2%
Operating Margin
-466.2%
Operating Margin = Operating Income / Revenue
Operating margin is the percentage of revenue remaining after operating expenses, reflecting operating efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | OPERATING MARGIN |
|---|---|
| 2026-06-30 | -1334.89% |
| 2026-03-31 | -343.08% |
| 2025-12-31 | -480.86% |
| 2025-09-30 | -412.97% |
| 2025-06-30 | -476.68% |
| 2025-03-31 | -500.53% |
| 2024-12-31 | -499.17% |
| 2024-09-30 | -466.48% |
| 2024-06-30 | -537.50% |
| 2024-03-31 | -512.50% |
| 2023-12-31 | -553.02% |
| 2023-09-30 | -887.17% |
| 2023-06-30 | -690.59% |
| 2023-03-31 | -493.58% |
| 2022-12-31 | 430.39% |
| 2022-09-30 | -813.33% |
| 2022-06-30 | -1008.32% |
| 2022-03-31 | -1213.61% |
| 2021-12-31 | -1680.60% |
| 2021-09-30 | 0.00% |
| 2021-06-30 | 0.00% |
| 2021-03-31 | 0.00% |
| 2020-12-31 | 0.00% |
| 2020-09-30 | 0.00% |
| 2020-06-30 | 0.00% |
| 2020-03-31 | 0.00% |
| 2019-12-31 | 0.00% |
| 2019-09-30 | 0.00% |
| 2019-06-30 | 0.00% |
| 2019-03-31 | 0.00% |
